Streamline Health Solutions, Inc. (STRM): Price and Financial Metrics

Streamline Health Solutions, Inc. (STRM): $1.25

0.06 (+5.04%)

POWR Rating

Component Grades













STRM Stock Summary

  • With a market capitalization of $79,493,059, Streamline Health Solutions Inc has a greater market value than only 13.02% of US stocks.
  • With a year-over-year growth in debt of 268.14%, Streamline Health Solutions Inc's debt growth rate surpasses 95.54% of about US stocks.
  • Over the past twelve months, STRM has reported earnings growth of 211.49%, putting it ahead of 90.22% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Streamline Health Solutions Inc, a group of peers worth examining would be CASI, TRIP, OM, BNGO, and FLDM.
  • STRM's SEC filings can be seen here. And to visit Streamline Health Solutions Inc's official web site, go to

STRM Valuation Summary

  • In comparison to the median Technology stock, STRM's price/sales ratio is 24.53% higher, now standing at 6.6.
  • STRM's price/sales ratio has moved up 5.6 over the prior 243 months.
  • STRM's price/sales ratio has moved up 5.6 over the prior 243 months.

Below are key valuation metrics over time for STRM.

Stock Date P/S P/B P/E EV/EBIT
STRM 2021-09-01 6.6 2.5 -13.8 -10.1
STRM 2021-08-31 6.4 2.4 -13.3 -9.6
STRM 2021-08-30 6.1 2.3 -12.7 -9.1
STRM 2021-08-27 6.4 2.4 -13.2 -9.6
STRM 2021-08-26 6.4 2.4 -13.2 -9.6
STRM 2021-08-25 6.0 2.3 -12.5 -8.9

STRM Growth Metrics

    Its 2 year revenue growth rate is now at -26.13%.
  • The 4 year revenue growth rate now stands at -36.73%.
  • Its 3 year net income to common stockholders growth rate is now at 6.45%.
Over the past 67 months, STRM's revenue has gone down $14,505,237.

The table below shows STRM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 14.307 -3.777 -7.699
2021-06-30 11.434 -5.323 -4.444
2021-03-31 11.453 -4.332 -5.519
2020-12-31 11.346 -5.757 0.296
2020-09-30 13.177 -5.035 -0.921
2020-06-30 16.324 -2.068 4.864

STRM Price Target

For more insight on analysts targets of STRM, see our STRM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.75 Average Broker Recommendation 1.5 (Moderate Buy)

STRM Stock Price Chart Interactive Chart >

Price chart for STRM

STRM Price/Volume Stats

Current price $1.25 52-week high $2.29
Prev. close $1.19 52-week low $1.13
Day low $1.17 Volume 90,300
Day high $1.25 Avg. volume 46,960
50-day MA $1.44 Dividend yield N/A
200-day MA $1.52 Market Cap 60.13M

Streamline Health Solutions, Inc. (STRM) Company Bio

Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers health information management; coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, such as computer-assisted coding, CDI, and abstracting and physician query; and eValuator, a cloud-based pre- and post-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration, training, electronic image conversion, audit, and database monitoring services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was founded in 1989 and is headquartered in Alpharetta, Georgia.

STRM Latest News Stream

Event/Time News Detail
Loading, please wait...

STRM Latest Social Stream

Loading social stream, please wait...

View Full STRM Social Stream

Latest STRM News From Around the Web

Below are the latest news stories about Streamline Health Solutions Inc that investors may wish to consider to help them evaluate STRM as an investment opportunity.

Streamline Health Solutions (STRM) Has a New Rating from Colliers Securities

Streamline Health Solutions (STRM – Research Report) received a Buy rating and a $2.50 price target from Colliers Securities analyst Kyle Bauser today. The company's shares closed last Wednesday at $1.45, close to its 52-week low of $1.22. According to, Bauser is ranked 0 out of 5 stars with an average return of -6.8% and a 35.1% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Chembio Diagnostics, and Semler Scientific. Currently, the analyst consensus on Streamline Health Solutions is a Moderate Buy with an average price target of $2.50.

Catie Powers on TipRanks | March 3, 2022

Streamline Health® Announces Preliminary Fourth Quarter Bookings and Fiscal Year 2021 Revenue

Atlanta, GA , Feb. 24, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced preliminary bookings results for the fourth quarter of fiscal 2021 and preliminary revenue results for the fiscal year ended January 31, 2022. The Company acquired Avelead Consulting, LLC on August 16, 2021, and all

Yahoo | February 24, 2022

Pennsylvania-Based Health System Signs New Contract for Streamline Health® eValuator™

Regional Provider Chooses Automated Coding Analysis for Inpatient and Outpatient Care to Improve Revenue Performance Atlanta, GA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced it has signed a contract with a seven hospital, Epic-EHR based health system in Pennsylvania. The system will use eValuator’s aut

Yahoo | February 22, 2022

Streamline Health® Announces Strategic Organizational Improvements to Accelerate Growth

Ben Stilwill promoted to President & CEO, eValuator Solutions; Amy Sebero appointed Chief Growth Officer, eValuator Solutions, bringing 40 years of healthcare software sales leadership Atlanta, GA, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that Ben Stilwill, previously S

Yahoo | February 17, 2022

Avelead Announces Expansion of Leadership Team

Sykes and Yzerman to Lead Innovation and Services Departments Atlanta, Georgia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Avelead, a Streamline Health Company (NASDAQ: STRM), today announced the expansion of its leadership team to include Sean Sykes, Chief Technology Officer, and Michael Yzerman, Senior Vice President of Services. Avelead established these leadership positions to effectively manage future growth, strengthen the Avelead Platform, including RevID – the industry-leading automated charge re

Yahoo | February 8, 2022

Read More 'STRM' Stories Here

STRM Price Returns

1-mo -10.71%
3-mo -13.79%
6-mo -19.87%
1-year -34.55%
3-year -9.42%
5-year 3.31%
YTD -16.11%
2021 -4.49%
2020 12.23%
2019 71.60%
2018 -52.07%
2017 35.20%

Continue Researching STRM

Want to see what other sources are saying about Streamline Health Solutions Inc's financials and stock price? Try the links below:

Streamline Health Solutions Inc (STRM) Stock Price | Nasdaq
Streamline Health Solutions Inc (STRM) Stock Quote, History and News - Yahoo Finance
Streamline Health Solutions Inc (STRM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.056 seconds.